Roadmap: Helium ion therapy

95Citations
Citations of this article
91Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Helium ion beam therapy for the treatment of cancerwas one of several developed and studied particle treatments in the 1950s, leading to clinical trials beginning in 1975 at the Lawrence Berkeley National Laboratory. The trial shutdown was followed by decades of research and clinical silence on the topic while proton and carbon ion therapymade debuts at research facilities and academic hospitalsworldwide.The lack of progression in understanding the principle facets of helium ion beam therapy in terms of physics, biological and clinical findings persists today, mainly attributable to its highly limited availability.Despite this major setback, there is an increasing focus on evaluating and establishing clinical and research programs using heliumion beams, with both therapy and imaging initiatives to supplement the clinical palette of radiotherapy in the treatment of aggressive disease and sensitive clinical cases. Moreover, due its intermediate physical and radio-biological properties between proton and carbon ion beams, helium ions may provide a streamlined economic steppingstone towards an era of widespread use of different particle species in light and heavy ion therapy. With respect to the clinical proton beams, helium ions exhibit superior physical properties such as reduced lateral scattering and range stragglingwith higher relative biological effectiveness (RBE) and dose-weighted linear energy transfer (LETd) ranging from 4keVum?1 to 40 keVum?1. In the frame of heavy ion therapy using carbon, oxygen or neon ions,where LETd increases beyond 100 keVum?1, helium ions exhibit similar physical attributes such as a sharp lateral penumbra, however,with reduced radio-biological uncertainties and without potentially spoiling dose distributions due to excess fragmentation of heavier ion beams, particularly for higher penetration depths. This roadmap presents an overviewof the current state-of-The-Art and future directions of heliumion therapy: understanding physics and improvingmodeling, understanding biology and improving modeling, imaging techniques using helium ions and refining and establishing clinical approaches and aims from learned experiencewith protons.These topics are organized and presented into three main sections, outlining current and future tasks in establishing clinical and research programs using helium ion beams A. PhysicsB.Biological and C. Clinical Perspectives.

Cite

CITATION STYLE

APA

Mairani, A., Mein, S., Blakely, E., Debus, J., Durante, M., Ferrari, A., … Weber, U. (2022). Roadmap: Helium ion therapy. Physics in Medicine and Biology, 67(15). https://doi.org/10.1088/1361-6560/ac65d3

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free